ABSTRACT Our laboratory is evaluating the efficacy of direct-fec! microbials (DFM) and phytogenic products to control Clostridium perfringens, a gram-positive organism associated with decreased performance and morbidity and mortality associated with necrotic enteritis, as well as some recent human food safety issues. Three experiments were conducted to evaluate a DFM (PoultryStar) and a phytogenic product (PEP125), which were administered to birds froni day of hatch until termination (d 25) via the drinking water or through supplementation to a wheat-corn diet, respectively. Each experiment contained a nonchallenged negative control and a positive control wherein birds were immunocompromised with a lOx dosage of infectious bursa] disease vaccine at 14 ci of age and subsequently gavaged with C. perfringens (10 cfu/mL) daily for 3 consecutive days starting on d 17. Intestinal lesions, mortality, and log 10 values of C. perfringens in the prohiotic and phytogenic treatment groups were found to be lower (P < 0.05) than those observed in the positive controls. These experiments suggest that the DFM and the phytogenic product could he used as potential alternatives to help control C. perfringens and necrotic enteritis.
INTRODUCTION
Clostridiurn perfringens is a spore-forming, grampositive, rod-shaped bacterium that grows in anaerobic conditions. These bacteria can be found in many areas of our environment and are ubiquitous in nature. Some of the primary host reservoirs of these bacteria include humans, cats, cows, pigs, sheep, and chickens (Maier et al., 2000) . In animal agriculture, poultry and beef products are the predominant food commodities of the meat industry, with annual human food consumption on a per capita basis of 149.6 and 138.6 kg, respectively, in the United States (Food Consumption, 2003) . Clostridium. perfringens is prevalent in commercial poultry. with 75 to 95% of the gastrointestinal tract of broilers having tested positive for C. per fringe us in previous studies (Tschirclewahn et al., 1991 : Miwa et al.. 1997 Craven et al., 2001a,b) . Processed poultry meat has also been shown to have relatively high numbers of C. perfringens from 8 to 84% (Miwa et al., 1997; Craven et al., 2001h ). This enteric pathogen, which is found throughout broiler production, may be transmitted to humans through ©2009 Poultr y Science Association Inc. the consumption of contaminated poultry products (Labbe. 1991; Craven et al.. 2001a.b) .
For the commercial poultry industry, controlling the levels of C. perfrinqens is an important issue because of the economic cost of infected flocks. It has been estimated that, worldwide, C. perfrirtqens costs the international poultry industry in excess of WS 2 billion per year (Kaldhusdal and L gvland. 2000) . Clostridiuirr perfringens is the etiologic agent of the disease necrotic enteritis (NE). The clinical signs of this disease include depression, decreased appetite, diarrhea, and severe necrosis of the gastrointestinal tract (Calnek, 1997) .
Understanding the disease progression of NE has been very difficult due to its complexity and several predisposing factors such as dietary components, immunosuppression, mechanical irritation of the gut. and sudden changes in gut microflora that appear to contribute to this syndrome (Smith. 1965 : Elwinger et al., 1992 : Calnek, 1997 . The gastrointestinal microbial community is a sophisticated association of many different species of bacteria with the flora differing from host to host. Interestingly, individual variations in microbial flora between birds may account for some of the differences in uniformity, birch performance, as well as disease susceptibility observed in commercial flocks. Denaturing gradient gel electrophoresis data from van der Widen et al. (2002) suggest that birds from the same flock share hacterial 2075 population similarities similarities of only 50%. These similarities are surprisingly small because birds grown in the same environment are, theoretically, exposed to the same environmental microbial flora. The low microbiologic similarities between birds may suggest that host factors such as host. immune status (Toivanen et al., 2001) , genotype, specific host receptors, or bacterial communication systems (Zoetendal et al. 2001 ) contribute significantly to the bacterial profile of the intestinal tract of individuals.
Probiotic direct-fed, microbial (D FM) products are composed of beneficial intestinal microflora from healthy adult chickens and are administered to neonatal chickens for the prevention of intestinal colonization by pathogens (Nurini and Rantala. 1973 : Snoeyenhos et al., 1979 : Barnes et al.. 1980 : Mead and Impey. 1986 Corner et al., 1995) . Direct-fed microbials are live, naturally occurring microorganisms that contribute to the health and balance of time microbiota in the intestinal tract. Direct-fed microbials are given orally to poultry in the first few days of life and in transitional (stressful) periods to aid in the maintenance of the health and performance of the birds. Piebiotics are noncligestible products and their effect in the diet is to promote the growth and proliferation of beneficial bacteria in the intestinal tract, thus enhancing the effect of DFM bacteria. The prehiotics used in the present investigation were phytogenic (PHYTO) feed additives based on a combination of essential oils and prehiotic substances formulated to maintain a, healthy gilt at times of digestive stress. A healthy gilt not only affects nutrient utilization by the animal but also has a considerable influence on the immune status of the animal. Poor digestion leads to increased amounts of nutrients available for pathogenic bacteria to use and rapidly multiply in the digestive tract, which call to enteric diseases. The present investigation was dcsigned to evaluate the effects of a DFM product and a phytogenic product during all induced (use of NE.
MATERIALS AND METHODS

Experimental Birds
Ross x Ross straight-run broiler chicks were obtained frorn a local commercial hatchery on cla y of hatch and were placed on clean pine shaving litter. Birds were reared in 2.4 rn x 1.2 in pens, allowing 0.12 m 2 of pen space per bird. Chicks were provided with water ad libitum and a wheat-corn-soy-based broiler starter diet at 55, 15, and 22%, respectively. The diet was further balanced following the NRC recommended levels for DLmnethionine. L-lvsine, animal-vegetable fat blend, limestone. nionodica.lciuju P0 1 , salt, trace minerals, and vitamins (NRC, 1994) . Hi gh concentrations of wheat were used in the diet because this kind of diet has been shown to exacerbate the outbreak of NE (Johnson and Pinedo. 1971 : Truscott and Al-Shcikhly. 1977 : Branton et al.. 1987 Riddell and Kong, 1992) . Technical procedures of this study were approved by the Institutional Animal Care and Use Committee.
Immunosuppression Vaccine Administration
As described previously, a commercial bursal disease vaccine was used as all in the present investigations (McReynolds et al., 2004) . All birds were administered the vaccine on d 14, at a level lOx the recommended dose of the manufacturer via ocular route to immunocompromise the chicks. Challenge doses, at these concentrations, were chosen based on previous research (data not shown) and birds have been known to show signs of the disease state.
C. perfringens Administration
Four field isolates of C. perf...nqens (type A) were collected fromcommercial flocks having NE, in different geographical locations (1 isolate from Texas and Virginia and 2 isolates from Georgia), and were isolated and cultured separately, then combined and provided to thie appropriate treatment groups (McReynolds et al., 2004) . For challenge, the isolates were grown in thioglycollate medium for 12 h, and all chicks except for the negative control were challenged via oral gayage (3 inL) with 10 c'fuof C. perfringens/mL for birds iii experiment 1 and 107 cfu of C. perfringens/mL for birds in experiments 2 and 3. Birds were administered C. perfrmngens twice daily for 3 consecutive days beginlung on d 17. Again, challenge doses, at these concentrations. were chosen based on previous research (data not shown) and have been known to show signs of NE with intestinal intestinal lesions.
Experimental Design
In experiment 1, birds were randoml y assigned to one of the following groups: negative control; positive control; PHYTO blend 1, 2. 3; or a DFM blend 1, 2 (n = 50 birds for all groups). Birds were fed the control diet or a diet that contained one of the PHYTO blends 1, 2, or 3. These products contain a proprietary PHYTO mixture containing, but not limited to, essential oil (citrus, oregano. annase) plant extracts arid fructooligosaccharides (PEP125, Biomin, San Antonio, TX). The 3 PIIYTO products contained all of the active ingredients with varying concentrations of each. The products were administered in the feed at a concentration of 1 kg/ton (US) of feed from clay of hatch until termination (ci 25) of the experiment. The DFvI blend 1 (PoultryStar, Biomimi) contained 1.3 x 100, and DFM blend 2 contained 1.4 x 1012 of lactic acid bacteria imicluding Enierococcus faecium. Pediococcus acidilactici, Bif'dobacteriu'rn a.nz'rrmaijs. and Lactobacillus reuteri. The products were administered through the drinking water at a concentration of 20 g/1,000 birds per day, which delivers 1 x 108 cfu/mL for DFM blend 1 and 1 x iü°f or DFM blend 2 from day of hatch until termination (d 25). The calculated water consumption was based on the NRC guidelines and averaged 225, 480, and 725 mL/bird per week (NRC, 1994) . In experiment 1, we evaluated several parameters throughout the study for each treatment group: total mortality (n = 50), microbial populations log 1 cfu of C. perfringems/g ( n = 10), and the development of clinical lesions (n = 24).
In 2 replicate studies, experiments 2 and 3, birds were randomly assigned to one of the following groups: negative control, positive control, prohiotic blend 1, PHYTO blend 1, or the combination of both products. The experimental procedures previously mentioned in experiment 1 were followed for both experiments. In experiment 2, we evaluated several parameters including the following: total mortality (ii = 37 positive controls, 74 for treatment groups) microbial populations log1 cfu of C. perfringens/g ( n = 10), and the development of clinical lesions (n = 24). In experiment 3, the same parameters were measured: total mortality (ii = 50 positive controls, 100 for treatment groups), microbial populations log 1() cfu of C. perfringens/g ( n = 10), and the development of clinical lesions (n = 40).
Bacterial Culture
To quantitatively measure populations of C. perfringems, a section of the small intestine approximately 15 cm in length, just cranial to Meckel's diverticulum, was removed. Each sample was placed in 10 mL of anaerobic thioglycollate, stormiached for 30 s, and a 0.5-mL aliquot of intestinal digesta was removed and placed into 4.5 mL of thioglycollate medium. Ten-fold serial dilutions were performed, plated on Shahidi-Ferguson perfringens agar, and incubated (24 h at 37CC). All of the C. perfringens culture work was performed in an anaerobic hood. Plates containing colonies exhibiting typical morphology with more than 30 or less than 300 colonies were counted and recorded.
NE Lesion Scores
To evaluate gross lesions associated with NE, the jejunum and ileum approximately 10 cm cranial and dorsal to Meckel's diverticulum were examined. Lesion scores were recorded using the following criteria (Prescott et al., 1978) : 0 = no gross lesions, normal intestinal appearance; 1 thin-walled or friable, gray appearance; 2 = thin-walled, focal necrosis, gray appearance, small amounts of gas production; 3 = thin walled, sizable patches of necrosis, gas-filled intestine, small flecks of blood; 4 = severe extensive necrosis, marked hernorrhage, large amounts of gas in intestine.
Statistical Analysis
Mortality among all treatment groups was compared using the x 2 test of independence (P < 0.05). All mortality data were based on the total number of birds per treatment group for individual experiments; all the other measured parameters were subsets of treatment groups, for individual experiments. Bacterial counts (log1(, units) were analyzed with the PROC MIXED procedure in SAS and adjusted for multiple comparisons using the Tukey option. To evaluate the lesion scores in the present investigation, the row mean scores were compared using the Cochran-Mantel-Haenszel testing PROC FREQ. The Cochran-Mantel-Haenszel test showed significant differences (P 0.05), and the data were further analyzed using a nonparamnetric ANOVA (Kruskal-Wallis) by ranking the scores, applying the mean to ties, and running a IROC CLM on the ranks, allowing the treatment groups to be compared by the mean ranks (SAS Institute. 1996) . Many of these organisms are opportunistic pathogens, and given the appropriate conditions. these bacteria will grow and flourish. A commensal intestinal microflora protects the host from these pathogens. However. if the commensal flora of the gut is disturbed, these pathogens can grow and cause disease such as NE (Van Imnierseel et al., 2004) .
RESULTS AND DISCUSSION
In experiment 1, we evaluated several different PHYTO blends and probiotic products to determine the optimal blend for efficac y iii reducing NE intestinal lesion development. The data from experiment 1 showed that PITYTO blends 1 amid 3 and DFM blends I and 2 were the most efficacious (P < 0.05) in reducing the severity of lesion scores when compared with the positive control, with mean lesion scores of 0.58, 0.75, and 0.29. 0.83, respectively, compared with 1.33 in time positive control (Table 1) . It is important to note the shift in lesiomi scores when evaluating the percentage of clinical intestinal lesion scores of the treatment groups compared with the positive controls. In experiment 1, more birds had a lesion score of 0 in the PHYTO blend 1 (63%) and DFM blend 2 (75%) treatment groups when compared with the positive controls (13%). This downshift in lesion lesion score severity is important because of intestinal integrity. If intestinal lesion scores can he reduced, the infected birds have a much greater chance of recovering from the disease. Although these birds will weigh significantly less when they recover from the disease, they will he marketable. Both of these products aided in the reduction of severity of lesions and promoted the maintenance of intestinal integrity. Mortality was also reduced (P < 0.05) in both the PHYTO blend 1 and DFM blend 1 treatment groups when compared 'Treatment groups represented by the PHYTO blends 1, 2, and 3 administered in the feed and the DFM blends 1 and 2 administered in the water or from d 1.
2Lesion score is represented by the mean of treatment subset (n = 24) with the MS error. "Mortality is represented by incidence data compared with the positive control ( 5 P 0.05, ii = 50). 4Log,,, cfu/g is represented by the mean of treatment subset (ii = It)).
with the positive control with 8 and 6%, respectively, compared with 26% mortality in the positive control treatment. The log 10 C. perfringens/g of intestinal contents was significantly reduced in the DFM blend 1 group with a log 111 value of 1.90 compared with 3.42 in the positive control.
In experiment 2 and 3, we refined the number of phytogenic and DFM goups to PHYTO blend 1 and DFM blend 1 to replicate the findings from experiment 1. In both replicate experiments, we observed similar findings in that lesion scores were reduced as well as mortality and log, 1 values of C. perfringeris, even under higher C. perfrinqens challenge levels (107 vs. 105 for experiment 1). In experiment 2, a numerical reduction in the mean lesion score in the PHYTO (0.96) and DFM (0.98) treatment groups and a significant reduction in the combined treatment group (0.78) was observed compared with the positive control (1.28; Table  2 ). Mean lesion scores in the PHYTO, DFM, and combination groups in experiment 3 were also significantly reduced (P < 0.05) when birds were supplemented with the PHYTO, DFM, and combination groups with scores of 1.2, 1.2, and 1.3, respectively, when compared with the positive control score of 2.15 (Table 3) . Mortality, in both experiments 2 and 3, was numerically reduced from 6 to 10%, depending on treatment group. Again, there were reductions in log 10 values (P < 0.05) in all of the treatment groups in experiment 2, with mean average log10 values of C. perfringens 3.69, 3.44, and 3.13 in the PHYTO, DFM, and combination groups, respectively, when compared with the positive control mean value of 4.79. In experiment 3, the PHYTO treatment group had a reduction (P < 0.05) in log 10 values with a mean of 2.87. Interestingly, population levels of C. pevfringens are unaltered in some of the experimental groups; however, intestinal lesion scores and mortality are reduced. The probiotic strains Enterococcus sp., Pediococcus sp., B'ifidobacteriurn. sp.. and Lactobacillus sp. support the establishment and stabilization of a beneficial and protective gut microflora and are able to selectively exclude pathogens from colonization due to the fast proliferation, colonization, and acidification in the gut. The beneficial bacteria in the gastrointestinal tract play several key roles in animal health. There are several advantages in the development of a normal nucroflora: these bacteria aid in colonization resistance, Competition for intestinal attachment sites, and stimulation 3.13" ' I\1eans witin,, the same column with no common superscripts differ significantl y (I' 0.05). 'Treatment groups represented by the PHYTO blends 1, 2, and 3 administered in the or from d 1.
feed and the DFM blends 1 and 2 administered in the water 1esion score is represented by the mean of treatment subset (n = 24) with the MS error. 3 GrAil 17/10)) (17%) 2.87°1 3/10)) (1337c) \lears within the Sante cohinm with no common superscripts differ sigitificati) lv (P < 0.05). 'Treatment groups represented by the PHYTO blends 1 2. and 3 administered in the feed and the DFM blends I and 2 administered in the water or from d 1.
'Lesion score is represented by the mean of treatment. subset (n = 40) with the MS error.
3Mortality is represented by incidence data compared with the positive control (n = 50). 'Log, 1 cfu/g is represented by the mean of treatment subset (ii = 10).
of the immune system (Nurmi et al., 1992) . The normal gut flora serves as the first line of defense against pathogens. The normal microbial flora employs various mechanisms that aid in the defense of the gastrointestinal tract of the host. One member of the normal bacterial microflora is Lactobacillus, which is capable of producing several compounds that aid in pathogen reduction. Reut.erin, a bacteriocin produced by Lactobacilli, has been shown in vitro to be inhibitory against. Salmonella, Shigella, Clostridium, and Listeria (Naicio et al.. 1999) . Many of the commensal bacteria produce compounds known as bacteriocins that affect both gram-positive and gram-negative bacteria. Other products sucil as hydrogen peroxide also are produced by commensal bacteria. Hydrogen peroxide results in the peroxidation of lipid membranes and increased bacterial membrane permeability. Other protective products include short-chain fatty acids, which are created by the commensal bacteria as an end product of microbial fermentation. These compounds are predominantly the volatile fatty acids, acetic, propionic, and butyric, and have been shown to be biological indicators of a healthy microbial ecosystem, as well as having inhibitory effects oIl pathogenic bacterial colonization in chickens (Nisbet et al., 1996) . The complexity of the disease processes involved in NE makes understanding, treating, and preventing this disease difficult. Clostridium perfringens produces a large variety of biologically active toxins that play significant roles in the pathogenicity of time organismn. The o. toxin is the most potent, extracellular toxin produced by C. perfringens and is responsible for the necrotic tissue formed in the disease condition. The (t toxiti contains phospliolipase C and sphingomyelinase enzymes that are highly active against epithelial cells, muscle cells, leukocytes, red blood cells, and platelets. These enzymes have been shown to have close interactions with the cell mnemnbrane and hydrolysis of sphingomycliii and phosphatidylcholine, resulting in l ysis of the cell (Titball, 1993; Murray et al., 1999) . When evaluating the log 1 cfu values of C. perfringens, we clearly see that the pathogenic bacteria are still in abundance and maintained at high concentrations in the gastrointestinal tract in all groups. However, even in relativel y high numbers, these bacteria and their toxins are having less of an effect on the intestinal cells, as can be seen in the reduced lesion scores associated within the phytogenic and probiotic treatment groups. Clostridium, is ubiquitous in nature and a resident of the normal intestinal ecology. Understanding the trigger mechanisms that cause this bacteria to grow rapidly and produce copious amounts of toxins that cause disease needs further investigation. Understanding this complex intestinal ecology and how to promote homeostasis is difficult because of the multitude of complex interactions between host and pathogen as well as coinmensal microbes.
Necrotic enteritis in poultry has been shown to be controlled by growth-promoting antibiotics such as hacitracin methylene disalicylate anti narasin. In a recent study. the combination of these antibiotics markedly reduced the clinical signs associated with NE (Brermnan et al., 2001) . Necrotic enteritis has been controlled using antimicrobials for many years in the poultry industry. However, if antibiotic compounds are removed from the market, this disease could prove to he costly to the poultry industry. A myriad of physiological parameters must be evaluated to better understand the interactions of phytogenic and DFM products on the development of NE. These nonantibiotic compounds have been shown to significantly increase man y positive attributes in the poultry industry from increasing production parameters to the prevention of disease caused by pathogenic bacteria. Furthermore, they have been shown to significantly reduce the effects of C. perfrinqens in the present investigations. Tile data, suggest that these products may provide the poultry industry with an alternative management tool that has the potential to promote better intestinal health and decrease monetary losses due to C. perfrinqens.
